Xiaoyang Wang Selected Research

Peptides (Polypeptides)

1/2020	Inhibiting the interaction between apoptosis-inducing factor and cyclophilin A prevents brain injury in neonatal mice after hypoxia-ischemia.
12/2014	The effect of osteopontin and osteopontin-derived peptides on preterm brain injury.
3/2013	Amelioration of arthritis through mobilization of peptide-specific CD8+ regulatory T cells.
9/2010	Neuroprotective effect of Bax-inhibiting peptide on neonatal brain injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoyang Wang Research Topics

Disease

45	Brain Injuries (Brain Injury) 01/2023 - 03/2005
34	Neoplasms (Cancer) 12/2023 - 11/2011
28	Hypoxia (Hypoxemia) 01/2023 - 07/2003
25	Inflammation (Inflammations) 12/2024 - 09/2006
24	Ischemia 01/2023 - 07/2003
18	Infections 12/2023 - 01/2012
12	Hemorrhage 04/2024 - 10/2014
10	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 11/2018 - 07/2003
8	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 02/2008
7	COVID-19 01/2023 - 10/2020
7	Lung Neoplasms (Lung Cancer) 01/2023 - 03/2002
7	Coccidiosis 12/2022 - 08/2014
6	Premature Birth (Birth, Premature) 12/2023 - 07/2010
6	Carcinogenesis 12/2023 - 02/2013
6	Necrosis 11/2023 - 03/2010
6	Body Weight (Weight, Body) 01/2022 - 11/2004
5	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 02/2014
5	Cerebral Palsy (Spastic Diplegia) 01/2023 - 06/2014
5	Infarction (Infarctions) 01/2019 - 07/2003
4	Neuroinflammatory Diseases 12/2023 - 12/2020
4	Hypertension (High Blood Pressure) 01/2023 - 02/2008
4	Diabetes Mellitus 01/2023 - 11/2020
4	Hyperlipidemias (Hyperlipidemia) 10/2022 - 11/2020
4	Disease Progression 01/2022 - 08/2011
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2019
4	Atrophy 03/2020 - 04/2013
4	Hypothermia 05/2012 - 01/2004
3	Malnutrition (Nutritional Deficiencies) 12/2024 - 01/2022
3	Colitis 05/2024 - 01/2022
3	Fibrosis (Cirrhosis) 03/2024 - 11/2016
3	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 11/2021
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2023 - 01/2022
3	Brain Neoplasms (Brain Tumor) 02/2022 - 01/2018
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021 - 02/2014
3	Retinopathy of Prematurity (Retrolental Fibroplasia) 10/2020 - 08/2011
3	Insulin Resistance 08/2020 - 12/2011
3	Virus Diseases (Viral Diseases) 01/2019 - 07/2013
2	Bacterial Infections (Bacterial Infection) 04/2024 - 01/2020
2	Non-alcoholic Fatty Liver Disease 04/2024 - 12/2011
2	Keloid 03/2024 - 01/2024
2	Asphyxia (Suffocation) 12/2023 - 01/2016
2	Autoimmune Diseases (Autoimmune Disease) 12/2023 - 03/2013
2	Dehydration (Water Stress) 08/2023 - 01/2021
2	Pneumonia (Pneumonitis) 08/2023 - 11/2022
2	Chronic Renal Insufficiency 01/2023 - 01/2022
2	Stroke (Strokes) 01/2023 - 01/2022

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 04/2024 - 07/2004
14	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2012
9	Apoptosis Inducing FactorIBA 11/2022 - 07/2003
9	CaspasesIBA 01/2020 - 01/2004
8	Transcription Factors (Transcription Factor)IBA 03/2024 - 07/2004
8	Caspase 3 (Caspase-3)IBA 01/2023 - 01/2004
8	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2011
8	CytokinesIBA 01/2021 - 12/2011
7	ethanamizurilIBA 12/2022 - 04/2018
7	Messenger RNA (mRNA)IBA 01/2022 - 07/2003
7	Erythropoietin FDA Link 10/2021 - 11/2004
6	Anti-Bacterial Agents (Antibiotics)IBA 08/2023 - 01/2015
6	Neuroprotective AgentsIBA 01/2023 - 03/2005
6	LipopolysaccharidesIBA 12/2009 - 09/2006
5	Therapeutic UsesIBA 05/2024 - 01/2020
5	VaccinesIBA 01/2023 - 08/2013
5	TriazinesIBA 11/2020 - 08/2014
4	IronIBA 11/2023 - 01/2019
4	Insulin-Like Growth Factor I (IGF-1)IBA 11/2023 - 03/2005
4	MagnesiumIBA 06/2023 - 11/2018
4	Oxygen (Dioxygen)IBA 01/2020 - 01/2006
4	Peptides (Polypeptides)IBA 01/2020 - 09/2010
4	LithiumIBA 01/2018 - 10/2011
4	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2015 - 12/2009
4	SaponinsIBA 02/2014 - 01/2013
3	AntioxidantsIBA 04/2024 - 12/2007
3	ChromatinIBA 11/2023 - 10/2019
3	OsteopontinIBA 06/2023 - 12/2014
3	LipidsIBA 10/2022 - 01/2018
3	Long Noncoding RNAIBA 03/2022 - 01/2021
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2007
3	camalexinIBA 01/2022 - 01/2019
3	Phosphotransferases (Kinase)IBA 11/2021 - 01/2009
3	NitrogenIBA 05/2021 - 04/2013
3	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2018 - 03/2002
3	2- (3- methyl- 4- (4- nitrophenoxy)phenyl)- 1,2,4- triazine- 3,5(2H,4H)- dioneIBA 08/2017 - 08/2014
3	Volatile Organic CompoundsIBA 08/2015 - 02/2014
2	Insulin-Like Growth Factor Binding ProteinsIBA 04/2024 - 11/2023
2	Small Interfering RNA (siRNA)IBA 04/2024 - 08/2012
2	Dextran SulfateIBA 12/2023 - 01/2022
2	Complement System Proteins (Complement)IBA 12/2023 - 01/2022
2	Cisplatin (Platino)FDA LinkGeneric 11/2023 - 11/2011
2	Cytotoxins (Cytolysins)IBA 11/2023 - 11/2011
2	Collagenases (Collagenase)FDA Link 11/2023 - 01/2020
2	Carrier Proteins (Binding Protein)IBA 11/2023 - 01/2021
2	CreatinineIBA 01/2023 - 05/2021
2	CholesterolIBA 01/2023 - 01/2022
2	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 02/2008

Therapy/Procedure

19	Therapeutics 05/2024 - 01/2011
14	Peritoneal Dialysis 12/2024 - 11/2020
9	Ligation 01/2023 - 07/2003
3	Radiotherapy 02/2022 - 01/2018
3	Artificial Respiration (Mechanical Ventilation) 03/2015 - 08/2013